Differentiating pulmonary hypertension associated with protein kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Differentiating pulmonary hypertension associated with protein kinase inhibitors

Published:2022-04 Issue:2 Volume:12 Page:
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Jacobs Joshua A.¹^ORCID,Jahangir Eiman²,Ryan John J.³

Affiliation:

1. Department of Pharmacy University of Utah Health Salt Lake City Utah USA

2. Division of Cardiovascular Medicine, Department of Medicine Vanderbilt University Nashville Tennessee USA

3. Division of Cardiovascular Medicine, Department of Medicine University of Utah Salt Lake City Utah USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pul2.12075

Reference160 articles.

1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

2. An overview of the 6th World Symposium on Pulmonary Hypertension

3. Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age

4. Tyrosine Kinase Inhibitor–Associated Cardiovascular Toxicity in Chronic Myeloid Leukemia

5. National Center for Biotechnology Information. 2021. Available from:https://pubchem.ncbi.nlm.nih.gov/compound

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP